KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Astrana Health (ASTH) over the last 17 years, with Q3 2025 value amounting to $462.2 million.

  • Astrana Health's Cash & Equivalents rose 3282.61% to $462.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $462.2 million, marking a year-over-year increase of 3282.61%. This contributed to the annual value of $288.5 million for FY2024, which is 182.16% down from last year.
  • Latest data reveals that Astrana Health reported Cash & Equivalents of $462.2 million as of Q3 2025, which was up 3282.61% from $339.7 million recorded in Q2 2025.
  • Astrana Health's 5-year Cash & Equivalents high stood at $462.2 million for Q3 2025, and its period low was $177.3 million during Q2 2021.
  • For the 5-year period, Astrana Health's Cash & Equivalents averaged around $276.8 million, with its median value being $274.6 million (2023).
  • Its Cash & Equivalents has fluctuated over the past 5 years, first skyrocketed by 15450.72% in 2021, then crashed by 2278.37% in 2025.
  • Quarter analysis of 5 years shows Astrana Health's Cash & Equivalents stood at $233.1 million in 2021, then increased by 23.57% to $288.0 million in 2022, then grew by 2.01% to $293.8 million in 2023, then decreased by 1.82% to $288.5 million in 2024, then soared by 60.24% to $462.2 million in 2025.
  • Its last three reported values are $462.2 million in Q3 2025, $339.7 million for Q2 2025, and $258.5 million during Q1 2025.